Switch to:
AbbVie Inc (NYSE:ABBV)
Piotroski F-Score
6 (As of Today)

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

AbbVie Inc has an F-score of 6 indicating the company's financial situation is typical for a stable company.

ABBV' s 10-Year Piotroski F-Score Range
Min: 6   Max: 6
Current: 6

During the past 5 years, the highest Piotroski F-Score of AbbVie Inc was 6. The lowest was 6. And the median was 6.


Definition

How is the Piotroski F-Score calculated?

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

This Year (Mar14) TTM:Last Year (Mar13) TTM:
Net Income was 980 + 1128 + 964 + 1068 = $4,140 Mil.
Cash Flow from Operations was 624 + 1245 + 1798 + 2037 = $5,704 Mil.
Revenue was 4563 + 5111 + 4658 + 4692 = $19,024 Mil.
Gross Profit was 3463 + 3829 + 3566 + 3638 = $14,496 Mil.
Total Assets at the begining of this year (Mar13) was $27,169 Mil.
Total Assets was $28,657 Mil.
Long-Term Debt was $14,386 Mil.
Total Current Assets was $17,329 Mil.
Total Current Liabilities was $6,216 Mil.
Net Income was 968 + 1540 + 1585 + 1267 = $5,360 Mil.

Revenue was 4329 + 5206 + 4508 + 4493 = $18,536 Mil.
Gross Profit was 3176 + 3941 + 3494 + 3420 = $14,031 Mil.
Total Assets at the begining of last year (Mar12) was $18,962 Mil.
Total Assets was $27,169 Mil.
Long-Term Debt was $14,601 Mil.
Total Current Assets was $14,923 Mil.
Total Current Liabilities was $6,766 Mil.

Profitability

Q1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by total assets at the beginning of the year.

Score 1 if positive, 0 if negative.

AbbVie Inc's current net income was 4,140. ==> Positive ==> Score 1.

Q2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by total assets at the beginning of the year.

Score 1 if positive, 0 if negative.

AbbVie Inc's current cash flow from operations was 5,704. ==> Positive ==> Score 1.

Q3. Change in Return on Assets

Compare this year’s return on assets (1) to last year’s return on assets.

Score 1 if it’s higher, 0 if it’s lower.

ROA (This Year)=Net Income/Total Assets at the beginning of this year (Mar13)
=4140/27169
=0.15237955

ROA (Last Year)=Net Income/Total Assets at the beginning of last year (Mar12)
=5360/18961.563
=0.28267712

AbbVie Inc's return on assets of this year was 0.15237955. AbbVie Inc's return on assets of last year was 0.28267712. ==> Last year is higher ==> Score 0.

Q4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA =< ROA.

AbbVie Inc's current net income was 4,140. AbbVie Inc's current cash flow from operations was 5,704. ==> 5,704 > 4,140 ==> CFROA > ROA ==> Score 1.

Funding

Q5. Change in Gearing or Leverage

Compare this year’s gearing (long-term debt divided by average total assets) to last year’s gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year)=Long-Term Debt/Total Assets
=14386/28657
=0.50200649

Gearing (Last Year)=Long-Term Debt/Total Assets
=14601/27169
=0.53741396

AbbVie Inc's gearing of this year was 0.50200649. AbbVie Inc's gearing of last year was 0.53741396. ==> This year is lower or equal to last year. ==> Score 1.

Q6. Change in Working Capital (Liquidity)

Compare this year’s current ratio (current assets divided by current liabilities) to last year’s current ratio.

Score 1 if this year'’s current ratio is higher, 0 if it’s lower

Current Ratio (This Year)=Total Current Assets/Total Current Liabilities
=17329/6216
=2.78780566

Current Ratio (Last Year)=Total Current Assets/Total Current Liabilities
=14923/6766
=2.20558676

AbbVie Inc's current ratio of this year was 2.78780566. AbbVie Inc's current ratio of last year was 2.20558676. ==> This year's current ratio is higher. ==> Score 1.

Q7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

AbbVie Inc's number of shares in issue this year was 1609. AbbVie Inc's number of shares in issue last year was 1605. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Q8. Change in Gross Margin

Compare this year’s gross margin (gross profit divided by sales) to last year’s.

Score 1 if this year’s gross margin is higher, 0 if it’s lower.

Gross Margin (This Year)=Gross Profit/Revenue
=14496/19024
=0.76198486

Gross Margin (Last Year)=Gross Profit/Revenue
=14031/18536
=0.75695943

AbbVie Inc's gross margin of this year was 0.76198486. AbbVie Inc's gross margin of last year was 0.75695943. ==> This year's gross margin is higher. ==> Score 1.

Q9. Change in asset turnover

Compare this year’s asset turnover (total sales divided by total assets at the beginning of the year) to last year’s asset turnover ratio.

Score 1 if this year’s asset turnover ratio is higher, 0 if it’s lower

Asset Turnover (This Year)=Revenue/Total Assets at the beginning of this year (Mar13)
=19024/27169
=0.7002098

Asset Turnover (Last Year)=Revenue/Total Assets at the beginning of last year (Mar12)
=18536/18961.563
=0.97755654

AbbVie Inc's asset turnover of this year was 0.7002098. AbbVie Inc's asset turnover of last year was 0.97755654. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score=Q1+Q2+Q3+Q4+Q5+Q6+Q7+Q8+Q9
=1+1+0+1+1+1+0+1+0
=6

Good or high score = 8 or 9

Bad or low score = 0 or 1

AbbVie Inc has an F-score of 6 indicating the company's financial situation is typical for a stable company.


Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Related Terms

Net Income, Cash Flow from Operations, Revenue, Gross Profit, Total Assets, Long-Term Debt, Total Current Assets, Total Current Liabilities


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

AbbVie Inc Annual Data

Dec09Dec10Dec11Dec12Dec13
Q1 1
Q2 1
Q3 0
Q4 1
Q5 1
Q6 1
Q7 0
Q8 1
Q9 0
F-score 6

AbbVie Inc Quarterly Data

Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14
Q1 11
Q2 11
Q3 00
Q4 11
Q5 11
Q6 11
Q7 00
Q8 11
Q9 00
F-score 0000000066
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide